Implication of the Hypothalamic-pituitary-adrenal Axis in the Physiopathology of Depression

Overview

Journal J Psychiatry Neurosci

Specialty Psychiatry

Date 2004 Jun 3

PMID 15173895

Citations 128

Authors

Nicholas Barden

Affiliations

Soon will be listed here.

Abstract

Major alterations of the hypothalamic-pituitary-adrenocortical (HPA) system that can be reversed by successful antidepressant therapy are often seen in depressed patients. Persuasive evidence points to the involvement of a dysfunctional glucocorticoid receptor (GR) system in these changes. Support for this also comes from studies of transgenic mice that express an antisense RNA, complementary to the GR mRNA, and have numerous neuroendocrine characteristics of human depression as well as altered behaviour. Many of these neuroendocrine and behavioural characteristics of the transgenic mice can be reversed by antidepressants. A possible explanation for this is that the antidepressant-induced increase in GRs renders the HPA axis more sensitive to glucocorticoid feedback. This new insight into antidepressant drug action suggests a novel approach to the development of antidepressant drugs.

Citing Articles

Fernandez-Pinteno A, Pilla R, Suchodolski J, Apper E, Torre C, Salas-Mani A Animals (Basel). 2025; 15(2).

PMID: 39858234 PMC: 11758293. DOI: 10.3390/ani15020234.

Mothering matters: Towards a better understanding of disrupted infant-caregiver relationships in both mother and offspring.

Rincon-Cortes M Neurobiol Stress. 2025; 34:100701.

PMID: 39801763 PMC: 11719408. DOI: 10.1016/j.ynstr.2024.100701.

Antidepressant- and Anxiolytic-Like Effect of the Froriepia subpinnata Extract in the Rat: Neurochemical Correlates.

Samandari-Bahraseman M, Esmaeilzadeh-Salestani K, Dogani M, Khaleghdoust B, Hatami N, Esmaeili-Mahani S Brain Behav. 2024; 14(11):e70171.

PMID: 39607287 PMC: 11603432. DOI: 10.1002/brb3.70171.

Potential role of gut microbiota in major depressive disorder: A review.

Khaledi M, Sameni F, Gholipour A, Shahrjerdi S, Golmohammadi R, Esmaeili Gouvarchin Ghaleh H Heliyon. 2024; 10(12):e33157.

PMID: 39027446 PMC: 11254604. DOI: 10.1016/j.heliyon.2024.e33157.

Tactile stimulation of young WAG/Rij rats prevents development of depression but not absence epilepsy.

Balikci A, Eryilmaz U, Guler V, Ilbay G Front Behav Neurosci. 2024; 18:1433431.

PMID: 38993266 PMC: 11236540. DOI: 10.3389/fnbeh.2024.1433431.

References

Bradbury M, Akana S, Cascio C, Levin N, Jacobson L, Dallman M . Regulation of basal ACTH secretion by corticosterone is mediated by both type I (MR) and type II (GR) receptors in rat brain. J Steroid Biochem Mol Biol. 1991; 40(1-3):133-42. DOI: 10.1016/0960-0760(91)90176-6. View

Benmansour S, Cecchi M, Morilak D, Gerhardt G, Javors M, Gould G . Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci. 1999; 19(23):10494-501. PMC: 6782424. View

Singh V, CORLEY K, Phan T, Boadle-Biber M . Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment. Brain Res. 1990; 516(1):66-76. DOI: 10.1016/0006-8993(90)90898-l. View

Murphy B, Filipini D, Ghadirian A . Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486. J Psychiatry Neurosci. 1993; 18(5):209-13. PMC: 1188541. View

Chalmers D, Lopez J, Vazquez D, Akil H, Watson S . Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone. Neuropsychopharmacology. 1994; 10(3):215-22. DOI: 10.1038/npp.1994.24. View

Maes M, Meltzer H, DHondt P, Cosyns P, Blockx P . Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoneuroendocrinology. 1995; 20(2):149-67. DOI: 10.1016/0306-4530(94)00049-g. View

Yau J, Seckl J . Central 6-hydroxydopamine lesions decrease mineralocorticoid, but not glucocorticoid receptor gene expression in the rat hippocampus. Neurosci Lett. 1992; 142(2):159-62. DOI: 10.1016/0304-3940(92)90363-c. View

Heuser I, Gotthardt U, Schweiger U, Schmider J, Lammers C, Dettling M . Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol Aging. 1994; 15(2):227-31. DOI: 10.1016/0197-4580(94)90117-1. View

Pepin M, Pothier F, Barden N . Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature. 1992; 355(6362):725-8. DOI: 10.1038/355725a0. View

10.

Brady L, Whitfield Jr H, Fox R, Gold P, Herkenham M . Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J Clin Invest. 1991; 87(3):831-7. PMC: 329870. DOI: 10.1172/JCI115086. View

11.

Dunn A, Berridge C . Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res Brain Res Rev. 1990; 15(2):71-100. DOI: 10.1016/0165-0173(90)90012-d. View

12.

Holsboer F, Gerken A, Stalla G, Muller O . ACTH, cortisol, and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery. Biol Psychiatry. 1985; 20(3):276-86. DOI: 10.1016/0006-3223(85)90057-5. View

13.

Peiffer A, Veilleux S, Barden N . Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology. 1991; 16(6):505-15. DOI: 10.1016/0306-4530(91)90034-q. View

14.

Beaulieu S, Di Paolo T, Cote J, Barden N . Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic systems. Neuroendocrinology. 1987; 45(1):37-46. DOI: 10.1159/000124701. View

15.

Young E, Haskett R, Grunhaus L, Pande A, Weinberg V, Watson S . Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry. 1994; 51(9):701-7. DOI: 10.1001/archpsyc.1994.03950090033005. View

16.

Reul J, Labeur M, Grigoriadis D, DE SOUZA E, Holsboer F . Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology. 1994; 60(5):509-19. DOI: 10.1159/000126788. View

17.

Raadsheer F, Hoogendijk W, STAM F, Tilders F, Swaab D . Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 1994; 60(4):436-44. DOI: 10.1159/000126778. View

18.

Nemeroff C, Owens M, Bissette G, Andorn A, Stanley M . Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry. 1988; 45(6):577-9. DOI: 10.1001/archpsyc.1988.01800300075009. View

19.

Barden N, Reul J, Holsboer F . Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?. Trends Neurosci. 1995; 18(1):6-11. DOI: 10.1016/0166-2236(95)93942-q. View

20.

Holsboer F, Gerken A, von Bardeleben U, Grimm W, Beyer H, Muller O . Human corticotropin-releasing hormone in depression--correlation with thyrotropin secretion following thyrotropin-releasing hormone. Biol Psychiatry. 1986; 21(7):601-11. DOI: 10.1016/0006-3223(86)90121-6. View